We’re making a difference in the health of people around the world by producing next generation vaccines that are accessible to more people. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our hopes. We do this work for the greater health of people everywhere. It’s more than our job. It’s our passion. Our Novavax Social Community Guidelines: https://www.novavax.com/social-media-community-guidelines
View Top Employees from NovavaxWebsite | https://www.novavax.com |
Ticker | NVAX |
Revenue | $34 million |
Funding | $3.2 billion |
Employees | 1,375 (1,375 on RocketReach) |
Founded | 1987 |
Address | 700 Quince Orchard Rd, Gaithersburg, Maryland 20878, US |
Phone | (240) 268-2000 |
Fax | (240) 268-2100 |
Technologies |
JavaScript,
HTML,
PHP
+67 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biopharma, Pharmaceuticals, Biotechnology, Healthcare, Health Care, Science and Engineering, Manufacturing, Medical |
Keywords | Vaccine Development, Infectious Disease |
Competitors | CureVac, Dynavax Technologies, Genocea, Medicago, Profectus BioSciences, Inc |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 4883 Companies, NAICS Code 48 Companies, NAICS Code 488 Companies |
Looking for a particular Novavax employee's phone or email?
The Novavax annual revenue was $34 million in 2024.
Filip Dubovsky is the President Research and Development of Novavax.
1,375 people are employed at Novavax.
Novavax is based in Gaithersburg, Maryland.
The NAICS codes for Novavax are [4883, 48, 488].
The SIC codes for Novavax are [873, 87].